Can Cogentin (benztropine) be used to treat akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cogentin (Benztropine) for Akathisia

Cogentin (benztropine) should NOT be used as a first-line treatment for akathisia, as anticholinergic agents are notably less effective for akathisia compared to other extrapyramidal side effects. 1

Why Benztropine Is Not Recommended for Akathisia

While benztropine is FDA-approved for drug-induced extrapyramidal disorders and can be used at 1-4 mg once or twice daily 2, the evidence specifically for akathisia is poor:

  • Anticholinergics are the least effective option among available treatments for akathisia, despite being commonly prescribed 1
  • In elderly patients with Alzheimer's disease receiving typical antipsychotics, guidelines explicitly recommend avoiding benztropine (Cogentin) when extrapyramidal symptoms occur 3
  • One controlled trial showed benztropine (6 mg/day) did improve akathisia by Day 3-5, but three patients developed confusion or forgetfulness requiring discontinuation 4

Recommended Treatment Algorithm for Akathisia

First-Line Approaches (in order of preference):

  1. Lower the antipsychotic dose while remaining in therapeutic range 1
  2. Switch to a lower-risk antipsychotic such as quetiapine or olanzapine 1
  3. Add propranolol 10-30 mg two to three times daily - this is the most consistently effective pharmacologic treatment 1, 5, 6

Second-Line Options:

  • Benzodiazepines (clonazepam) for symptomatic relief, particularly addressing the anxiety component 1
  • Mirtazapine has good evidence support 5

Third-Line Options:

  • Clonidine 6, 7
  • Amantadine (mild dopaminergic agent) 1

Critical Clinical Pitfall

Akathisia is frequently misinterpreted as psychotic agitation or anxiety, leading clinicians to inappropriately increase the antipsychotic dose, which worsens the condition 1. Look for the characteristic objective signs: continual rocking, leg shuffling, pacing, crossing and uncrossing legs while sitting, and marching in place 5, 7.

When Benztropine Might Be Considered

If you must use an anticholinergic (after first-line options have failed or are contraindicated), benztropine can be tried at 1-4 mg once or twice daily 2, but:

  • Monitor closely for anticholinergic side effects, especially confusion and memory impairment 3, 4
  • Be particularly cautious in elderly patients and children/adolescents 3, 1
  • Recognize this is an off-label, evidence-poor choice for akathisia specifically

References

Guideline

Treatment Options for Akathisia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.